Skip to search formSkip to main contentSkip to account menu

immunomycin

Known as: changchuanmycin, tacrolimus related compound A, 15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-4,10,12,18-tetram 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

Anti-Bacterial AgentsImmunosuppressive AgentsTacrolimus

Narrower (2)

FK 520FR 900520
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Determination of ascomycin in fermentation broth by reversed-phase liquid chromatography
Reversed-phase liquid chromatography(RP-HPLC) for the quantitative determination of ascomycin in the fermentation broth was… 
2006
2006
COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND mTOR KINASE INHIBITOR
FIELD: medicine, pharmaceutics. SUBSTANCE: there are offered a pharmaceutical combination for treating a proliferative disease… 
2005
2005
Synthetic modifications of ascomycin. V: Access to novel ascomycin derivatives by replacement of the cyclohexylvinylidene subunit
Starting from the easily accessible 24-O-tert-butyldimethylsilyl-22(R)-dihydro-28-oxoascomycin, methodologies that allow… 
2003
2003
Entstehungsgeschichte und präklinisches Profil von Pimecrolimus
ZusammenfassungPimecrolimus (SDZ ASM 981), ein Vertreter der neuen Verbindungsklasse der Ascomycine, hemmt die Phosphatase… 
2003
2003
Topical anhydrous and ethanol-free ascomycin compositions
The invention i) C ii) a fatty alcohol; And iii) a) an alkane carboxylic acid alkyl ester and (or) alkane dicarboxylic acid alkyl… 
2002
2002
Ophthalmic composition comprising an ascomycin
The present invention relates to a composition for ophthalmic administration comprising an ascomycin for once daily. 
Review
2000
Review
2000
New approaches to topical therapy
Despite the rapid and proven efficacy of topical corticosteroids, side‐effects can limit their clinical usefulness. Topically… 
2000
2000
Ascomycin derivatives and their use as immunosuppressive agents
2000
2000
Synthetic Modifications of Ascomycin. Part 3. A Concise Transformation of iso-Ascomycin to 19,20-seco-Derivatives.
A short transformation of 22(R)-dihydro-iso-ascomycin to novel 19, 20-seco-iso-ascomycin derivatives is described . The… 
1998
1998
32-Ascomycinyloxyacetic acid derived immunosuppressants. Independence of immunophilin binding and immunosuppressive potency.
The potent immunosuppressant ascomycin (1b) was selectively alkylated at the C-32 carbinol, thus providing esters and amides of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)